Key result
Wrist-worn wearable devices accurately measured induced supraventricular tachycardia heart rate within ±5 bpm of an ECG in 83.3% to 89.7% of cases, with no significant difference between devices.
Why the study?
Wrist-worn wearable devices are used by patients to monitor heart rate during palpitations, but few validation studies have evaluated their accuracy.
Do wrist-worn wearable devices accurately measure heart rate during paroxysmal supraventricular tachycardia compared to ECG in patients undergoing electrophysiological study?
Cross-Sectional (n=51)
Randomly assigned to wear 2 different devices
No
Do wrist-worn wearable devices accurately measure heart rate during paroxysmal supraventricular tachycardia compared to ECG in patients undergoing electrophysiological study?
Wrist-worn wearable devices, particularly the Apple Watch, demonstrated high accuracy in measuring heart rate during induced paroxysmal supraventricular tachycardia compared to standard ECG.
Answers are grounded in this paper and cite their sources.
Wearable HR readings during palpitations warrant caution in paroxysmal SVT; leaves open need for larger validation studies.
BACKGROUND AND OBJECTIVES: Wrist-worn wearable devices provide heart rate (HR) monitoring function via photoplethysmography technology. Recently, these devices have been used by patients to measure the HR when palpitation occurs, but few validation studies of these instruments have been conducted. We assessed the accuracy of these devices for measuring a HR. METHODS: This study enrolled 51 consecutive patients with a history of paroxysmal supraventricular tachyarrhythmia (SVT) or paroxysmal palpitations who were scheduled to undergo an electrophysiological study (EPS). Three devices were assessed: Apple Watch Series 2 (Apple), Samsung Galaxy Gear S3 (Galaxy), and Fitbit Charge 2 (Fitbit). Patients were randomly assigned to wear 2 different devices. The HR at baseline and induced SVT were measured during the EPS. After successful ablation of SVT, HR measurements was also done during atrial and ventricular pacing study. RESULTS: The mean patient age was 44.4±16.6 years and 27 patients were male (53%). The accuracy (within ±5 beats per minute [bpm] of an electrocardiogram [ECG] measurement) of the baseline HR measurements was 100%, 100%, and 94%, for Apple, Galaxy, and Fitbit, respectively. The HR during induced SVT ranged from 108 bpm to 228 bpm and the accuracy (within ±10 bpm of an ECG) was 100%, 90%, and 87% for the Apple, Galaxy, and Fitbit, respectively. During pacing study, accuracy of these devices was also acceptable but tended to decrease as the HR increased, and showed differences between the devices. CONCLUSIONS: Wrist-worn wearable devices accurately measure baseline and induced SVT HR. TRIAL REGISTRATION: Clinical Research Information Service Identifier: KCT0002282.
No takes yet. Share an insight, caveat, or question.
Hwang et al. (2019) conducted a cross-sectional in Paroxysmal supraventricular tachyarrhythmia (n=51). Wrist-worn wearable devices (Apple Watch Series 2, Samsung Galaxy Gear S3, Fitbit Charge 2) vs. 12-lead electrocardiogram was evaluated on Accuracy of heart rate measurement within ±5 bpm of an electrocardiogram during induced supraventricular tachycardia (p=0.780). Wrist-worn wearable devices accurately measured induced supraventricular tachycardia heart rate within ±5 bpm of an ECG in 83.3% to 89.7% of cases, with no significant difference between devices.
Synapse has enriched 10 related papers. Consider them for comparative context: